Carl Zeiss Meditec (ETR:AFX) received a €54.00 ($66.67) price objective from stock analysts at Independent Research in a research report issued on Monday. The firm presently has a “neutral” rating on the stock. Independent Research’s price objective would indicate a potential upside of 8.43% from the company’s previous close.
Several other brokerages have also weighed in on AFX. Deutsche Bank set a €40.00 ($49.38) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 1st. Berenberg Bank set a €55.00 ($67.90) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, January 12th. Nord/LB set a €60.00 ($74.07) target price on shares of Carl Zeiss Meditec and gave the stock a “buy” rating in a research note on Tuesday, December 12th. Commerzbank set a €42.00 ($51.85) target price on shares of Carl Zeiss Meditec and gave the stock a “neutral” rating in a research note on Friday, December 8th. Finally, DZ Bank reaffirmed a “sell” rating on shares of Carl Zeiss Meditec in a research note on Thursday, October 19th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have issued a buy rating to the company. Carl Zeiss Meditec presently has an average rating of “Hold” and an average target price of €52.75 ($65.12).
Shares of Carl Zeiss Meditec (AFX) opened at €49.80 ($61.48) on Monday. Carl Zeiss Meditec has a 1-year low of €36.56 ($45.14) and a 1-year high of €55.25 ($68.21). The stock has a market cap of $4,400.00 and a PE ratio of 31.72.
ILLEGAL ACTIVITY NOTICE: “Carl Zeiss Meditec (AFX) Given a €54.00 Price Target by Independent Research Analysts” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/02/12/carl-zeiss-meditec-afx-given-a-54-00-price-target-by-independent-research-analysts.html.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.